Prognostic impact of CD109 expression in myxofibrosarcoma.
about
CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.Soft tissue myxofibrosarcoma: A clinico-pathological analysis of a series of 75 patients with emphasis on the epithelioid variant.Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.Myxofibrosarcoma primary cultures: molecular and pharmacological profile.Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.CD109 and squamous cell carcinoma.
P2860
Prognostic impact of CD109 expression in myxofibrosarcoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Prognostic impact of CD109 expression in myxofibrosarcoma.
@en
type
label
Prognostic impact of CD109 expression in myxofibrosarcoma.
@en
prefLabel
Prognostic impact of CD109 expression in myxofibrosarcoma.
@en
P2093
P2860
P356
P1476
Prognostic impact of CD109 expression in myxofibrosarcoma.
@en
P2093
Kenji Murata
Makoto Emori
Mikito Sasaki
Mitsunori Kaya
Noriyuki Sato
Satoshi Nagoya
Shintaro Sugita
Tadashi Hasegawa
Takuro Wada
Tamotsu Soma
P2860
P304
P356
10.1002/JSO.23934
P577
2015-05-28T00:00:00Z